Grünenthal and SEDISA join forces against the pain.

– in a first phase will organize workshops on the management of pain and biomedical innovation within the framework of the 17th National Congress of hospitals

Madrid, 2011-March Grünenthal Pharma S.A. and the Spanish society of health management (SEDISA) have signed a collaboration agreement to promote the proper management of pain in the Spanish health care system and raising the awareness of society about this disease. The Alliance between the laboratory and the Group of professionals dedicated to the management of health will allow to organize a workshop on the management of pain in health centres ” and other on hospital biomedical research, economic dynamism, and progress ”, in the next National Congress of hospitals to be held between April 27-29.

During the ceremony of the signing of the agreement, representatives of both organizations have highlighted the importance of this Alliance. Our priority is to improve the health and quality of life of patients suffering from pain. And this goal can only be achieved her if we count with the collaboration and experience of those professionals who in the same way, ensuring the well-being of the population ”, assured William Castle, CEO of Grünenthal Iberia

in this sense, SEDISA represents a landmark in the integration of professionals dedicated to the management and offers a path to an important collective responsible for optimizing the resources for the proper functioning of hospitals ”, has been secured. Thanks to our experience in the treatment of pain, will provide useful tools for the most appropriate decision-making in hospital management, members of SEDISA ” has highlighted Castle.

For its part, Joaquín Estévez, President of SEDISA, wanted to highlight the importance of this agreement to combat the pain. We have the knowledge and means to avoid that people suffer from pain, but sometimes we forget to put the patient at the Centre of our attention. To do so, must receive the members of the World Health – clinicians, managers, business – as allies, not parties in a relationship for the sale. The agreement between Grünenthal, one of the pioneers and leaders in the field of pain, and SEDISA will help to restore the focus on the patient ”.

In the same vein, Lourdes Gonzalez, Manager of SEDISA has explained that Grünenthal will bring their experience and knowledge in the promotion of training activities on the treatment of pain and its approach ”. The first activities promoted by this collaboration be carried out within the framework of the 17TH National Congress of hospitals which will take place over the next days 27-29 April. Under the title Integral management of pain in health centres ”, speakers of high prestige in the field of pain, such as the doctors Rafael Galvez, head of the unit of pain and care palliative of the Hospital Virgen de las Nieves (Granada), and José María Muñoz and Ramón, head of the unity of the pain of the Hospital Universitario la Paz and project director Hospital without pain ”, will offer his views on the need for a correct treatment, as well as the necessary measures to implement it.

from left to right: William Castle, CEO of Grünenthal Iberia and Joaquín Estévez, President of SEDISA.

Also, Castillo announced Grünenthal and SEDISA collaborate through a second workshop entitled hospital biomedical research, economic dynamism, and progress ”.

Later, this Convention has agreed to organize a regional Conference to address topics of interest according to the needs detected among the members of SEDISA. This agreement ”, completed Castle, Grünenthal continues commitment to working together and encouraging all those projects that contribute to improving the quality of life of patients with pain, in line with the interests and needs of the companies related to the health ”.

Caption (from left to right): Guillermo Castillo, director general of Grünenthal Iberia and Joaquín Estévez, President of SEDISA.

About Grünenthal

Grünenthal is a pharmaceutical company regarding worldwide in the treatment of pain, both for patients and for doctors and health managers. Innovation is one of its fundamental principles and one of the keys to be leaders in the global market for moderate to severe pain. Grünenthal is an independent German company family-owned, with offices in 35 countries around the world. Founded in 1946, Grünenthal has 512 employees in the region of Iberia and approximately 4,900 at the global level. In 2009 the global sales figures reached the 881 million euros.

About SEDISA

SEDISA is an Association of private and non-profit-making, with legal personality independent of its members and itself, and with full legal capacity to administer and dispose of their assets and serve the purposes proposed. Purposes of SEDISA consist of the implementation of many activities contribute to the promotion, development, protection and defence of the health services in general and particularly the study and development of health management and leadership functions, as well as representation, management and defence of the professional interests of its members.